MEXICOR IN THE COMBINATION THERAPY OF CHRONIC HEART FAILURE AND TYPE 2 DIABETES MELLITUS
The study included 60 patients, aged 45-65 years, with Functional Class II-III chronic heart failure (CHF) in early post-infarction period and Type 2 diabetes mellitus (DM-2). The participants were randomised into two groups (n=30 for each group). In the main group, Mexicor (0,4 g/d) was added to th...
| Autori principali: | , , |
|---|---|
| Natura: | Articolo |
| Lingua: | Russian |
| Pubblicazione: |
«FIRMA «SILICEA» LLC
2011-12-01
|
| Serie: | Российский кардиологический журнал |
| Soggetti: | |
| Accesso online: | https://russjcardiol.elpub.ru/jour/article/view/1174 |